ADA Scientific Sessions 2026 Abstract·6 JunUnderstanding the Lived Experiences of Dosing Practices among People Living with Obesity (PwO) Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Weight Loss (WL): A U.S. Qualitative StudyStudy in peoplePopulationsPaper